首页> 外文期刊>生物化学与生物物理学报:英文版 >Floralozone protects endothelial function in atherosclerosis by ameliorating NHE1
【24h】

Floralozone protects endothelial function in atherosclerosis by ameliorating NHE1

机译:花花杆子通过改善NHE1保护动脉粥样硬化中的内皮功能

获取原文
获取原文并翻译 | 示例
       

著录项

  • 来源
    《生物化学与生物物理学报:英文版》 |2021年第10期|1310-1320|共11页
  • 作者单位

    College of Pharmacy Xinxiang Medical University Xinxiang 453003 China;

    Henan International Joint Laboratory of Cardiovascular Remodeling and Drug Intervention Xinxiang 453003 China;

    Xinxiang Key Laboratory of Vascu-lar Remodeling Intervention and Molecular Targeted Therapy Drug Development Xinxiang 453003 China;

    School of Basic Medical Sciences Xinxiang Medical University Xinxiang 450003 China;

    College of Pharmacy Xinxiang Medical University Xinxiang 453003 China;

    Henan International Joint Laboratory of Cardiovascular Remodeling and Drug Intervention Xinxiang 453003 China;

    Xinxiang Key Laboratory of Vascu-lar Remodeling Intervention and Molecular Targeted Therapy Drug Development Xinxiang 453003 China;

    College of Pharmacy Xinxiang Medical University Xinxiang 453003 China;

    Henan International Joint Laboratory of Cardiovascular Remodeling and Drug Intervention Xinxiang 453003 China;

    Xinxiang Key Laboratory of Vascu-lar Remodeling Intervention and Molecular Targeted Therapy Drug Development Xinxiang 453003 China;

    College of Pharmacy Xinxiang Medical University Xinxiang 453003 China;

    Henan International Joint Laboratory of Cardiovascular Remodeling and Drug Intervention Xinxiang 453003 China;

    Xinxiang Key Laboratory of Vascu-lar Remodeling Intervention and Molecular Targeted Therapy Drug Development Xinxiang 453003 China;

    College of Pharmacy Xinxiang Medical University Xinxiang 453003 China;

    Henan International Joint Laboratory of Cardiovascular Remodeling and Drug Intervention Xinxiang 453003 China;

    Xinxiang Key Laboratory of Vascu-lar Remodeling Intervention and Molecular Targeted Therapy Drug Development Xinxiang 453003 China;

    College of Pharmacy Xinxiang Medical University Xinxiang 453003 China;

    Henan International Joint Laboratory of Cardiovascular Remodeling and Drug Intervention Xinxiang 453003 China;

    Xinxiang Key Laboratory of Vascu-lar Remodeling Intervention and Molecular Targeted Therapy Drug Development Xinxiang 453003 China;

    College of Pharmacy Xinxiang Medical University Xinxiang 453003 China;

    Henan International Joint Laboratory of Cardiovascular Remodeling and Drug Intervention Xinxiang 453003 China;

    Xinxiang Key Laboratory of Vascu-lar Remodeling Intervention and Molecular Targeted Therapy Drug Development Xinxiang 453003 China;

    College of Pharmacy Xinxiang Medical University Xinxiang 453003 China;

    Henan International Joint Laboratory of Cardiovascular Remodeling and Drug Intervention Xinxiang 453003 China;

    Xinxiang Key Laboratory of Vascu-lar Remodeling Intervention and Molecular Targeted Therapy Drug Development Xinxiang 453003 China;

    College of Pharmacy Xinxiang Medical University Xinxiang 453003 China;

    Henan International Joint Laboratory of Cardiovascular Remodeling and Drug Intervention Xinxiang 453003 China;

    Xinxiang Key Laboratory of Vascu-lar Remodeling Intervention and Molecular Targeted Therapy Drug Development Xinxiang 453003 China;

    Henan Key Laboratory of Immunology and Targeted Drugs School of Laboratory Medicine Xinxiang Medical University Xinxiang 453003 China;

    Henan Collaborative Innovation Center of Molecular Diagnosis and Laboratory Medicine School of Laboratory Medicine Xinxiang Medical University Xinxiang 453003 China;

  • 收录信息
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类
  • 关键词

获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号